Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/164829
Title: Procalcitonin to stop antibiotics after cardiovascular surgery in a pediatric intensive care unit-The PROSACAB study.
Author: Bobillo Pérez, Sara
Solé Ribalta, Anna
Balaguer Gargallo, Mònica
Esteban Torné, Elisabeth
Girona-Alarcon, Monica
Hernandez-Platero, L.
Segura-Matute, Susana
Felipe-Villalobos, Aida
Cambra Lasaosa, Francisco José
Launes Montaña, Cristian
Jordán García, Iolanda
Keywords: Medicina intensiva
Pediatria
Antibiòtics
Critical care medicine
Pediatrics
Antibiotics
Issue Date: 18-Sep-2019
Publisher: Public Library of Science (PLoS)
Abstract: Introduction and objective: Children admitted to the pediatric intensive care unit after cardiovascular surgery usually require treatment with antibiotics due to suspicion of infection. The aim of this study was to assess the effectiveness of procalcitonin in decreasing the duration of antibiotic treatment in children after cardiovascular surgery. Methods: Prospective, interventional study carried out in a pediatric intensive care unit. Included patients under 18 years old admitted after cardiopulmonary bypass. Two groups were compared, depending on the implementation of the PCT-guided protocol to stop or de-escalate the antibiotic treatment (Group 1, 2011-2013 and group 2, 2014-2018). This new protocol was based on the decrease of the PCT value by 20% or 50% with respect to the maximum value of PCT. Primary endpoints were mortality, stewardship indication, duration of antibiotic treatment, and antibiotic-free days. Results: 886 patients were recruited. There were 226 suspicions of infection (25.5%), and they were confirmed in 38 cases (16.8%). The global rate of infections was 4.3%. 102 patients received broad-spectrum antibiotic (4.7±1.7 days in group 1, 3.9±1 days in group 2 with p = 0.160). The rate of de-escalation was higher in group 2 (30/62, 48.4%) than in group 1 (24/92, 26.1%) with p = 0.004. A reduction of 1.1 days of antibiotic treatment (group 1, 7.7±2.2 and group 2, 6.7±2.2, with p = 0.005) and 2 more antibiotic free-days free in PICU in group 2 were observed (p = 0.001), without adverse outcomes. Conclusions: Procalcitonin-guided protocol for stewardship after cardiac surgery seems to be safe and useful to decrease the antibiotic exposure. This protocol could help to reduce the duration of broad-spectrum antibiotics and the duration of antibiotics in total, without developing complications or adverse effects.
Note: Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0220686
It is part of: PLoS One, 2019, vol. 14, num. 9, p. e0220686
URI: http://hdl.handle.net/2445/164829
Related resource: https://doi.org/10.1371/journal.pone.0220686
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
692590.pdf1.18 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons